Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Lord

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Cancer Biology & Therapy|October 28, 2005
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potencyNuala McCabe, Christopher J Lord, Andrew N J Tutt, et al.
EMBO Reports|December 3, 2005
p53 modulates homologous recombination by transcriptional regulation of the RAD51 geneCarmen Arias-Lopez, Iciar Lazaro-Trueba, Peter Kerr, et al.
Molecular Cancer Therapeutics|March 1, 2006
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatmentBenjamin J Friedmann, Martyn Caplin, Boris Savic, et al.
The Journal of Pathology|August 15, 2009
Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formationAfshan McCarthy, Christopher J Lord, Kay Savage, et al.
Molecular Cancer Therapeutics|February 13, 2015
Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR PathwaysMarieke Aarts, Ilirjana Bajrami, Maria T Herrera-Abreu, et al.
The EMBO Journal|April 5, 2008
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitorNicholas C Turner, Christopher J Lord, Elizabeth Iorns, et al.
Plos Genetics|February 16, 2021
Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cellsAndrey A Parkhitko, Arashdeep Singh, Sharon Hsieh, et al.
Oncogene|June 20, 2018
Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancerRachel Brough, Aditi Gulati, Syed Haider, et al.
Nature Communications|May 24, 2018
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targetsDragomir B Krastev, Stephen J Pettitt, James Campbell, et al.
Breast Cancer Research and Treatment|January 27, 2009
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell linesAlan Mackay, Narinder Tamber, Kerry Fenwick, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Cancer Biology & Therapy|October 28, 2005
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potencyNuala McCabe, Christopher J Lord, Andrew N J Tutt, et al.
EMBO Reports|December 3, 2005
p53 modulates homologous recombination by transcriptional regulation of the RAD51 geneCarmen Arias-Lopez, Iciar Lazaro-Trueba, Peter Kerr, et al.
Molecular Cancer Therapeutics|March 1, 2006
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatmentBenjamin J Friedmann, Martyn Caplin, Boris Savic, et al.
The Journal of Pathology|August 15, 2009
Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formationAfshan McCarthy, Christopher J Lord, Kay Savage, et al.
Molecular Cancer Therapeutics|February 13, 2015
Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR PathwaysMarieke Aarts, Ilirjana Bajrami, Maria T Herrera-Abreu, et al.
The EMBO Journal|April 5, 2008
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitorNicholas C Turner, Christopher J Lord, Elizabeth Iorns, et al.
Plos Genetics|February 16, 2021
Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cellsAndrey A Parkhitko, Arashdeep Singh, Sharon Hsieh, et al.
Oncogene|June 20, 2018
Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancerRachel Brough, Aditi Gulati, Syed Haider, et al.
Nature Communications|May 24, 2018
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targetsDragomir B Krastev, Stephen J Pettitt, James Campbell, et al.
Breast Cancer Research and Treatment|January 27, 2009
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell linesAlan Mackay, Narinder Tamber, Kerry Fenwick, et al.
Pageof 23